Origin Bancorp, Inc. (NYSE:OBK) Q4 2024 Results Conference Call January 23, 2025 9:00 AM ET Company Participants Chris Reigelman – Director, Investor RelationsDrake Mills...
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Ray Furey – EVP, General Counsel and...
Cardlytics, Inc. (NASDAQ:CDLX) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Nick Lynton – Chief, Legal and Privacy Officer...
Alsea, S.A.B. de C.V. (OTCPK:ALSSF) Q2 2023 Earnings Call Transcript July 27, 2023 10:00 AM ET Company Participants Nicolás Espinoza Meneses – IR Armando...
Introduction TG Therapeutics, Inc. (NASDAQ:TGTX) develops and markets treatments for B-cell malignancies and autoimmune diseases. Their FDA-approved product, Briumvi, is a monoclonal antibody therapy...